
Glimpen M 2mg/500mg Tablet SR
Marketer
Alencure Biotech Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimpen M 2mg/500mg Tablet SR
Diabetic patients may find relief with Glimpen M 2mg/500mg SR tablets, an anti-diabetic medication combining two active ingredients. This formulation is indicated for adult type 2 diabetes management, helping regulate blood glucose. Administer this extended-release tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle modifications are vital for effective diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Be prepared to treat this with readily available glucose sources (e.g., sugary snacks, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before starting treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are recommended.
Uses of Glimpen M 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimpen M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpen M 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.
Common Side effects of Glimpen M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimpen M 2mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Glimpen M 2mg/500mg Sustained-Release tablet should be taken with a meal.
How Glimpen M 2mg/500mg Tablet SR works:
Glipen M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimpen M 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimpen M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingUNSAFE
Prolonged-release Glimpen M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimpen M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimpen M 2mg/500mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Glimpen M 2mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver disease, initiate Glimpen M 2mg/500mg SR tablets at a reduced dosage; its use is contraindicated in those with severe liver dysfunction.
What if you forget to take Glimpen M 2mg/500mg Tablet SR :
Should you forget to take a Glimpen M 2mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimpen M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Medication for diabetes |
